is .5 semaglutide effective - Uses | Limitations Semaglutide or Tirzepatide: Which is

Abstract The STEP 5 trial assessed the efficacy and safety of once-weekly subcutaneous semaglutide 2.4 mg versus placebo (both plus behavioral intervention) for long-term treatment of adults with obesity, or overweight with at least one weight-related comorbidity, without diabetes

Mounjaro and Zepbound (tirzepatide) target an additional hormone called GIP, producing even greater average weight loss

Sedating antihistamines should be avoided, particularly in older adults or those who must avoid impairment

Some individuals tolerate semaglutide better, while others respond more comfortably to tirzepatide

Ive felt more motivated to stick with my healthy living plan